» Articles » PMID: 20171957

Organic Cation Transporter Inhibition Increases Medial Hypothalamic Serotonin Under Basal Conditions and During Mild Restraint

Overview
Journal Brain Res
Specialty Neurology
Date 2010 Feb 23
PMID 20171957
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The dorsomedial hypothalamus (DMH) has been implicated in the coordination of stress responses. Restraint stress or systemic corticosterone (CORT) treatment induces a rapid increase in tissue concentrations of serotonin (5-hydroxytryptamine; 5-HT) in the DMH. Although the mechanism for rapid changes in 5-HT concentrations in the DMH is not clear, earlier results suggest that stress-induced increases in CORT may inhibit 5-HT transport from the extracellular fluid by acting on corticosterone-sensitive organic cation transporters (OCTs). We tested the hypothesis that perfusion of the medial hypothalamus (MH), which includes the DMH, with the OCT blocker decynium 22 (D-22) would potentiate the effects of mild restraint on extracellular 5-HT. Male Sprague-Dawley rats, implanted with a microdialysis probe into the MH, were treated with reverse-dialysis of D-22 (20 microM; 40 min) or vehicle and subjected to either 40 min mild restraint or undisturbed control conditions. Perfusates collected from a separate group of rats were evaluated for the effect of restraint on extracellular CORT concentrations in the MH. Reverse-dialysis of D-22 induced an increase (200%) in extracellular 5-HT concentrations in the MH in undisturbed control rats. Restraint in the absence of D-22 did not significantly affect MH CORT or 5-HT concentrations. However, perfusion of the MH with D-22 during restraint led to an increased magnitude and duration of extracellular 5-HT concentrations, relative to D-22 by itself. These results are consistent with the hypothesis that OCTs in the DMH contribute to the clearance of 5-HT from the extracellular fluid under both baseline conditions and mild restraint.

Citing Articles

Corticosterone rapidly modulates dorsomedial hypothalamus serotonin and behavior in an estrogen- and progesterone-dependent manner in adult female rats: potential role of organic cation transporter 3 (OCT3).

Scholl J, Rogers J, Feng N, Forster G, Watt M, Yaeger J Stress. 2025; 28(1):2457765.

PMID: 39898528 PMC: 11801257. DOI: 10.1080/10253890.2025.2457765.


All the brain's a stage for serotonin: the forgotten story of serotonin diffusion across cell membranes.

Andrews P, Bosyj C, Brenton L, Green L, Gasser P, Lowry C Proc Biol Sci. 2022; 289(1986):20221565.

PMID: 36321487 PMC: 9627707. DOI: 10.1098/rspb.2022.1565.


Organic Cation Transporters in Psychiatric Disorders.

Daws L Handb Exp Pharmacol. 2021; 266:215-239.

PMID: 34282486 PMC: 9281871. DOI: 10.1007/164_2021_473.


Genetic and Epigenetic Regulation of Organic Cation Transporters.

Kolz C, Schaeffeler E, Schwab M, Nies A Handb Exp Pharmacol. 2021; 266:81-100.

PMID: 33674913 DOI: 10.1007/164_2021_450.


Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Fraser-Spears R, Krause-Heuer A, Basiouny M, Mayer F, Manishimwe R, Wyatt N Eur J Pharmacol. 2018; 842:351-364.

PMID: 30473490 PMC: 6440482. DOI: 10.1016/j.ejphar.2018.10.028.


References
1.
Vialou V, Balasse L, Callebert J, Launay J, Giros B, Gautron S . Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem. 2008; 106(3):1471-82. DOI: 10.1111/j.1471-4159.2008.05506.x. View

2.
Amphoux A, Vialou V, Drescher E, Bruss M, Mannoury la Cour C, Rochat C . Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006; 50(8):941-52. DOI: 10.1016/j.neuropharm.2006.01.005. View

3.
Mo B, Feng N, Renner K, Forster G . Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res Bull. 2008; 76(5):493-8. PMC: 2474795. DOI: 10.1016/j.brainresbull.2008.02.011. View

4.
Zhou M, Engel K, Wang J . Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol. 2006; 73(1):147-54. PMC: 1828907. DOI: 10.1016/j.bcp.2006.09.008. View

5.
Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y . Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett. 2005; 382(1-2):195-200. DOI: 10.1016/j.neulet.2005.03.014. View